Myelofibrosis: Treatment Progress

Listen Now

Topics Covered

• Overview & Updates on Myelofibrosis (MF) in the Context of Infectious Diseases
• Staging & Diagnosing
• Current Standard of Care
• New & Emerging Treatment Approaches
• Understanding Common Signs & Symptoms
• Strategies to Reduce Potential Complications of MF
• Clinical Trial Updates
• How Research Contributes to Treatment Options
• Working with the Health Care Team to Manage Symptoms, Treatment Side Effects, Discomfort & Pain
• The Importance of Adherence to Treatment
• Communicating with Your Health Care Team About Staging & Progression
• Talking with Your Doctor About What Symptoms Should Prompt You or Your Caregiver to Call the Office
• Quality-of-Life Concerns & Recommendations to Improve Your Quality-of-Life
• Nutrition & Hydration Concerns & Tips
• Guidelines to Prepare for Telehealth/Telemedicine Appointments with Your Health Care Team, Including Technology, Prepared List of Questions & Discussion of OpenNotes
• Questions for Our Panel of Experts

Our Panel of Experts

Aaron T. Gerds, MD, MS

Associate Professor of Medicine, Hematology & Medical Oncology, Deputy Director for Clinical Research, Cleveland Clinic Taussig Cancer Institute, Medical Director, Case Comprehensive Cancer Center, Clinical Research Office, Principal Investigator, Case Lead Academic Participating Site

Michael Grunwald, MD, FACP

Professor, Wake Forest University School of Medicine, Chief, Leukemia Section, Atrium Health Levine Cancer Institute, Director, Transplantation and Cellular Therapy Program, Atrium Health Levine Cancer Institute

Douglas Tremblay, MD

Associate Professor, Icahn School of Medicine at Mount Sinai

Diana L. Bearden, MS, RD, CSO, LD, CNSC

Oncology Dietitian, Michael E. DeBakey VA Medical Center

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on December 03, 2025.